相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Probenecid Relieves Cerebral Dysfunction of Sepsis by Inhibiting Pannexin 1-Dependent ATP Release
Zhanqin Zhang et al.
INFLAMMATION (2019)
Retardation of Axonal and Dendritic Outgrowth Is Associated with the MAPK Signaling Pathway in Offspring Mice Following Maternal Exposure to Nanosized Titanium Dioxide
Yingjun Zhou et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
The Role of Connexin and Pannexin Channels in Perinatal Brain Injury and Inflammation
Kelly Q. Zhou et al.
FRONTIERS IN PHYSIOLOGY (2019)
Pannexin 1 Regulates Network Ensembles and Dendritic Spine Development in Cortical Neurons
Juan C. Sanchez-Arias et al.
ENEURO (2019)
Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease
Angela Gomez-Arboledas et al.
GLIA (2018)
Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease
David Baglietto-Vargas et al.
AGING CELL (2018)
An isoform-selective p38α mitogen-activated protein kinase inhibitor rescues early entorhinal cortex dysfunctions in a mouse model of Alzheimer's disease
Grazia Rutigliano et al.
NEUROBIOLOGY OF AGING (2018)
Pannexin-1 channels contribute to seizure generation in human epileptic brain tissue and in a mouse model of epilepsy
Elena Dossi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Lack of Pannexin 1 Alters Synaptic GluN2 Subunit Composition and Spatial Reversal Learning in Mice
Ivana Gajardo et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
SB203580 reverses memory deficits and depression-like behavior induced by microinjection of Aβ1-42 into hippocampus of mice
Jiejie Guo et al.
METABOLIC BRAIN DISEASE (2017)
Inhibition of glial hemichannels by boldine treatment reduces neuronal suffering in a murine model of Alzheimer's disease
Chenju Yi et al.
GLIA (2017)
Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony
Stefania Forner et al.
TRENDS IN NEUROSCIENCES (2017)
Pannexin 1 Modulates Axonal Growth in Mouse Peripheral Nerves
Steven M. Horton et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Neuronal p38α mediates synaptic and cognitive dysfunction in an Alzheimer's mouse model by controlling β-amyloid production
Sandra Colie et al.
SCIENTIFIC REPORTS (2017)
Probenecid arrests the progression of pronounced clinical symptoms in a mouse model of multiple sclerosis
Nadine Hainz et al.
SCIENTIFIC REPORTS (2017)
Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study
Na Lu et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis
Nadine Hainz et al.
INFLAMMATION (2016)
Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer's disease
C. Yi et al.
CELL DEATH AND DIFFERENTIATION (2016)
Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer's Disease Mouse Models
Saktimayee M. Roy et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Hemichannels Are Required for Amyloid β-Peptide-Induced Degranulation and Are Activated in Brain Mast Cells of APPswe/PS1dE9 Mice
Paloma A. Harcha et al.
JOURNAL OF NEUROSCIENCE (2015)
Pannexin-1-mediated ATP release from area CA3 drives mGlu5-dependent neuronal oscillations
Jan Lopatar et al.
NEUROPHARMACOLOGY (2015)
PROBENECID PROTECTS AGAINST CEREBRAL ISCHEMIA/REPERFUSION INJURY BY INHIBITING LYSOSOMAL AND INFLAMMATORY DAMAGE IN RATS
R. Wei et al.
NEUROSCIENCE (2015)
Gout and the risk of dementia: a nationwide population-based cohort study
Jen-Yee Hong et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Correlation of Hippocampal Volume and Cognitive Performances in Patients with Either Mild Cognitive Impairment or Alzheimer's disease
Guo-Ping Peng et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Neuronal cytoskeleton in synaptic plasticity and regeneration
Phillip R. Gordon-Weeks et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology
Katherine A. Price et al.
MOLECULAR NEURODEGENERATION (2014)
The synaptic plasticity and memory hypothesis: encoding, storage and persistence
Tomonori Takeuchi et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Pannexin 1 regulates bidirectional hippocampal synaptic plasticity in adult mice
Alvaro O. Ardiles et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo
Neng-Wei Hu et al.
NATURE COMMUNICATIONS (2014)
Powerful partnership: crosstalk between pannexin 1 and the cytoskeleton
Andrew K. J. Boyce et al.
FRONTIERS IN PHYSIOLOGY (2014)
Panx1 regulates neural stem and progenitor cell behaviours associated with cytoskeletal dynamics and interacts with multiple cytoskeletal elements
Leigh E. Wicki-Stordeur et al.
CELL COMMUNICATION AND SIGNALING (2013)
Probenecid: An Emerging Tool for Neuroprotection
Ana Laura Colin-Gonzalez et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2013)
ENHANCEMENT OF LONG-TERM DEPRESSION BY SOLUBLE AMYLOID β PROTEIN IN RAT HIPPOCAMPUS IS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR AND INVOLVES ACTIVATION OF P38MAPK, STEP AND CASPASE-3
X. Chen et al.
NEUROSCIENCE (2013)
NMDA-Receptor Activation but Not Ion Flux Is Required for Amyloid-Beta Induced Synaptic Depression
Albert Tamburri et al.
PLOS ONE (2013)
Metabotropic NMDA receptor function is required for β-amyloid-induced synaptic depression
Helmut W. Kessels et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model
Hiromitsu Negoro et al.
SCIENTIFIC REPORTS (2013)
The History and Future of Probenecid
Nathan Robbins et al.
CARDIOVASCULAR TOXICOLOGY (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's disease
Alvaro O. Ardiles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease
Marc Aurel Busche et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Synapses and Alzheimer's Disease
Morgan Sheng et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Soluble Oligomers of Amyloid-β Peptide Disrupt Membrane Trafficking of α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Contributing to Early Synapse Dysfunction
Alfredo J. Minano-Molina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels
Juan A. Orellana et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Amyloid β-Induced Death in Neurons Involves Glial and Neuronal Hemichannels
Juan A. Orellana et al.
JOURNAL OF NEUROSCIENCE (2011)
Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors
Shaomin Li et al.
JOURNAL OF NEUROSCIENCE (2011)
Interactions of human organic anion transporter 1 (hOAT1) with substances associated with forensic toxicology
Shoetsu Chiba et al.
LEGAL MEDICINE (2011)
Cognitive effects of cell-derived and synthetically derived Aβ oligomers
Miranda N. Reed et al.
NEUROBIOLOGY OF AGING (2011)
Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices
Gerhard Rammes et al.
NEUROPHARMACOLOGY (2011)
Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus
Paul Carrillo-Mora et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
Hiroaki Fukumoto et al.
FASEB JOURNAL (2010)
Animal models of amyloid-beta-related pathologies in Alzheimer's disease
Ola Philipson et al.
FEBS JOURNAL (2010)
Pannexin1 and Pannexin3 Delivery, Cell Surface Dynamics, and Cytoskeletal Interactions
Ruchi Bhalla-Gehi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Long-term depression in the CNS
Graham L. Collingridge et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Non-junction functions of pannexin-1 channels
Brian A. MacVicar et al.
TRENDS IN NEUROSCIENCES (2010)
Automated 3D Mapping of Hippocampal Atrophy and Its Clinical Correlates in 400 Subjects with Alzheimer's Disease, Mild Cognitive Impairment, and Elderly Controls
Jonathan H. Morra et al.
HUMAN BRAIN MAPPING (2009)
The Pannexin 1 Channel Activates the Inflammasome in Neurons and Astrocytes
William R. Silverman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake
Shaomin Li et al.
NEURON (2009)
Cytoskeletal Pathologies of Alzheimer Disease
James R. Bamburg et al.
CELL MOTILITY AND THE CYTOSKELETON (2009)
Probenecid, a gout remedy, inhibits pannexin 1 channels
William Silverman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Dennis J. Selkoe
BEHAVIOURAL BRAIN RESEARCH (2008)
Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-β-mediated cortical synaptic dysfunction
Nicola Origlia et al.
JOURNAL OF NEUROSCIENCE (2008)
Amyloid β protein dimer-containing human CSF disrupts synaptic plasticity:: Prevention by systemic passive immunization
Igor Klyubin et al.
JOURNAL OF NEUROSCIENCE (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy
Lorenzo A. Cingolani et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Animal models of Alzheimer's disease and frontotemporal dementia
Jurgen Gotz et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Activation of Pannexin-1 Hemichannels Augments Aberrant Bursting in the Hippocampus
Roger J. Thompson et al.
SCIENCE (2008)
Alzheimer disease models and human neuropathology: similarities and differences
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2008)
Structural plasticity of axon terminals in the adult
Nadine Gogolla et al.
CURRENT OPINION IN NEUROBIOLOGY (2007)
Transient receptor potential V2 expressed in sensory neurons is activated by probenecid
Sangsu Bang et al.
NEUROSCIENCE LETTERS (2007)
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease
Jorge J. Palop et al.
NEURON (2007)
Novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model
Lenka Munoz et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway
Ganesh M. Shankar et al.
JOURNAL OF NEUROSCIENCE (2007)
Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease
Pascale N. Lacor et al.
JOURNAL OF NEUROSCIENCE (2007)
Pannexin1 is expressed by neurons and glia but does not form functional gap junctions
Yan Huang et al.
GLIA (2007)
AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss
Helen Hsieh et al.
NEURON (2006)
Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity:: a potent role for trimers
M Townsend et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Molecular mechanisms of dendritic spine morphogenesis
T Tada et al.
CURRENT OPINION IN NEUROBIOLOGY (2006)
Pannexin1 and Pannexin2 expression in the developing and mature rat brain
A Vogt et al.
MOLECULAR BRAIN RESEARCH (2005)
Regulation of NMDA receptor trafficking by amyloid-β
EM Snyder et al.
NATURE NEUROSCIENCE (2005)
Dendritic spines and long-term plasticity
M Segal
NATURE REVIEWS NEUROSCIENCE (2005)
Natural oligomers of the amyloid-protein specifically disrupt cognitive function
JP Cleary et al.
NATURE NEUROSCIENCE (2005)
Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5
QW Wang et al.
JOURNAL OF NEUROSCIENCE (2004)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
p38 Kinase Is Activated in the Alzheimer's Disease Brain
Kenneth Hensley et al.
JOURNAL OF NEUROCHEMISTRY (2003)
p38 MAP kinase is activated at early stages in Alzheimer's disease brain
AY Sun et al.
EXPERIMENTAL NEUROLOGY (2003)
Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
YS Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Inflammatory processes in Alzheimer's disease
EG McGeer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Structural changes at dendritic spine synapses during long-term potentiation
KM Harris et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2003)
β-Amyloid peptide induces formation of actin stress fibers through p38 mitogen-activated protein kinase
C Song et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus
HW Wang et al.
BRAIN RESEARCH (2002)
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
HF Dovey et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Alzheimer's disease: Genes, proteins, and therapy
DJ Selkoe
PHYSIOLOGICAL REVIEWS (2001)
SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampus
G Saleshando et al.
NEUROSCIENCE LETTERS (2000)
High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice:: Synaptotoxicity without plaque formation
L Mucke et al.
JOURNAL OF NEUROSCIENCE (2000)
Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite function
LS Minamide et al.
NATURE CELL BIOLOGY (2000)
分享论文
